STOKStoke Therapeutics, Inc.

$30.03

What is the market doing?

What the tape says about STOK

Stoke Therapeutics, Inc. is +62% over the past year while the S&P 500 is +20%: 42 points ahead of the market.

+62%

1-year return · S&P 500 +20%

vs 200-day average
−4.8%

vs 200-day average · below trend, but not far

RSI (14)
38

RSI (14) · neutral

Below its 52-week high
22%

Below its 52-week high

2024-08-15$5.90 – $38.35 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$30.03
1 monthS&P 500 −0.30%
−5.9%
1 yearS&P 500 +20%
+62%
5 yearsS&P 500 +85%
+16%
vs 50-day average$30.68
−2.1%
52-week high
$38.35
52-week low
$18.49
Annualised volatility
65%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$552K
Calendar-year price return
YearReturn
2026 (year to date)−5.4%
2025+188%
2024+110%
2023−43%
2022−62%
2021−61%
2020+119%
Average return by calendar month, 2019–2026
MonthYearsPositiveAverage
Jan72 of 7−3.4%
Feb73 of 7+3.9%
Mar72 of 7+1.1%
Apr73 of 7−3.0%
May74 of 7+13%
Jun72 of 7−2.2%
Jul84 of 8−3.7%
Aug85 of 8+13%
Sep82 of 8−9.5%
Oct75 of 7+11%
Nov73 of 7−2.5%
Dec75 of 7+12%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.